BIOMAT Database Logo BIOMAT Database Logo

Treatment and prognosis of Hodgkin's disease. 1965

L F Craver, and D G Miller

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

L F Craver, and D G Miller
Hodgkin's disease; treatment and prognosis.
January 1946, The New England journal of medicine,
L F Craver, and D G Miller
Hodgkin's Disease: Treatment and Prognosis.
March 1982, Canadian family physician Medecin de famille canadien,
L F Craver, and D G Miller
[TREATMENT AND PROGNOSIS OF HODGKIN'S DISEASE].
January 1965, Journal de radiologie, d'electrologie, et de medecine nucleaire,
L F Craver, and D G Miller
Hodgkin's disease: biology, treatment, prognosis.
May 1981, Blood,
L F Craver, and D G Miller
Diagnosis, prognosis and treatment of Hodgkin's disease.
July 1955, Maroc medical,
L F Craver, and D G Miller
The treatment and prognosis of Hodgkin's disease.
October 1965, Journal of the Royal College of Surgeons of Edinburgh,
L F Craver, and D G Miller
Hodgkin's disease; clinical aspects, treatment, and prognosis.
April 1955, The Journal of the Faculty of Radiologists. Faculty of Radiologists (Great Britain),
L F Craver, and D G Miller
Hodgkin's disease and allied disorders, prognosis and treatment.
October 1949, Northwest medicine,
L F Craver, and D G Miller
[Hodgkin's disease. Pathological anatomy, diagnosis, prognosis, treatment].
October 1992, La Revue du praticien,
L F Craver, and D G Miller
[Treatment and prognosis of intrathoracic Hodgkin's disease (author's transl)].
May 1975, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!